T. Rowe Price Associates »

Nurix Therapeutics shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Nurix Therapeutics (NRIX) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Nurix Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nurix Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nurix Therapeutics by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2024-09-30 $69M 3.1M 22.47
2024-06-30 $59M 2.8M 20.88
2024-03-31 $32M 2.2M 14.70
2023-12-31 $25M 2.4M 10.32
2023-09-30 $19M 2.4M 7.86
2023-06-30 $24M 2.4M 9.99
2023-03-31 $23M 2.6M 8.88
2022-12-31 $36M 3.3M 10.98
2022-03-31 $67M 4.8M 14.01
2021-12-31 $141M 4.9M 28.95
2021-09-30 $141M 4.7M 29.96
2021-06-30 $108M 4.1M 26.53
2021-03-31 $96M 3.1M 31.09
2020-12-31 $20M 592k 32.88
2020-09-30 $20M 563k 34.91